An Open Label, Multiple-dose, Phase 1 Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects
Latest Information Update: 18 Jul 2018
At a glance
- Drugs PHP 201 (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Pharmacokinetics
- Sponsors pH Pharma
Most Recent Events
- 18 Jul 2018 New trial record